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Technology and social media have dramatically altered the landscape in which we practice medicine. Clinicians
have increasingly turned to technology and the internet to enhance patient care. Allergists have used these
modalities to improve utilization and adherence to immunotherapy. Electronic medical records (EMRs) are being
widely adopted by allergy practices and some offer allergy/immunology specific modules that aid in daily workflow.
The development of specialized devices that reduce pain associated with immunotherapy administration may
improve compliance with immunotherapy. Social media and other forms of electronic communication such as
e-mail, Facebook, Twitter, short message service (SMS), and YouTube give clinicians multiple avenues to disseminate
information and reach their patients, possibly improving patient adherence to therapy. Finally, tablet computers, online
networks, and electronic surveys provide additional ways to connect patients and physicians.
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A common challenge in the treatment of chronic ill-
nesses is patient nonadherence to medication regimens.
Studies on sublingual immunotherapy (SLIT) have dem-
onstrated that 55% to 82% of patients are noncompliant
with the recommended course of treatment [1]. Adher-
ence to subcutaneous immunotherapy has varied widely
ranging from 13%-89% [2]. Technological innovations
and social media have significantly influenced dissemin-
ation of information across all areas of medicine. The
use of these tools provides a potentially powerful avenue
to educate patients and improve utilization and adher-
ence to immunotherapy. The advantages and drawbacks
of these tools are summarized in Table 1. Most of the
technology discussed in the article is fairly new and
therefore studies of each individual tool and its impact
on adherence are limited or still in early stages.Review
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article, unless otherwise stated.Some EMRs commonly used by allergists in the United
States (US) include GE Centricity, Allscripts, EPIC,
Meditab-IMS, NextGen, ModuleMD, eClinical Works,
Rosch, and a free web-based EMR called Practice Fusion
[3]. Many EMRs have allergy/immunology specific mod-
ules. Such software is tailored towards allergists’ needs
and allows for features such as management of injections,
documentation of skin test results, and immunotherapy
documentation and billing. Some of these modules also in-
clude features that may improve immunotherapy adher-
ence by generating reports of patients late for injections
and creating batch reminder e-mails/letters. EMRs with
both full versions as well as allergy/immunology and
immunotherapy specific modules include Meditab/Allergy-
EHR [4], Module MD [5], and Mountainside Software [6].
Rosch Visionary Systems offers an immunotherapy module
that can interface with an existing EMR [7]. Both the
American Academy of Allergy, Asthma, and Immunology
(AAAAI) and American College of Allergy, Asthma and
Immunology (ACAAI) have online buyer’s guides that can
help prospective clients find suitable EMRs [8]. Scientific
societies provide guidance to their members regarding best
practices for use of EMRs and other new technologies for
improving adherence.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Advantages and limitations of technology in immunotherapy
Technology Advantages Limitations
Electronic Medical Records (EMRs) -Improve efficiency and workflow -No studies have evaluated if this
modality improves utilization and
adherence of immunotherapy
-Allergy/immunology specific modules allow for management of
injections, documentation of skin test results, and immunotherapy
documentation and billing. -Cost
-Some modules can generate reports of patients late for injections
and can create batch reminder e-mails/letters
Commercially available
devices aimed at reducing
pain with injections
-Use of vibration in the vicinity of intended injection site supposedly
reduces pain associated with injections
-No studies have evaluated if this
modality improves utilization and
adherence of immunotherapy-May improve patient satisfaction and adherence to treatment.
-Cost
Social Media
Twitter -Increasing presence of allergists using Twitter to
disseminate information
-No studies have evaluated if these
modalities improves utilization and
adherence of immunotherapy-Twitter is used by allergists at the meetings of AAAAI, ACAAI,
EAACI, and WAO -Difficulty validating authors’
credentials and qualifications
YouTube -Has been used by AAAAI, ACAAI, and EAACI to
disseminate information
-Information anarchy
-Allergists can use YouTube to post educational videos and then
embed them into their website. They can also embed videos
created by reputed health organizations
-Difficulty finding time to use social
media by physicians
Online Networks -Provide forum for allergists and patients to engage in
real-time collaboration








-Daily SMS reminders have improved adherence of medication
treatment outcomes in allergic rhinitis.
-No studies have evaluated if this
modality improves utilization and
adherence of immunotherapy
Electronic Surveys -Have been used to assess immunotherapy practices and utilization -No studies have evaluated if this
modality improves utilization and
adherence of immunotherapy
-Have been used to assess characteristics of patients living with allergies
Tablet Computers -Graphic display and ease of interface -No studies have evaluated if this
modality improves utilization and
adherence of immunotherapy
-Point-of-care tablet computers have been shown to
improve allergy/immunology education
Joshi and Dimov World Allergy Organization Journal 2014, 7:29 Page 2 of 6
http://www.waojournal.org/content/7/1/29New devices aim to decrease pain of subcutaneous
immunotherapy
There are several commercially available devices aimed
at reducing pain associated with injections and other in-
vasive medical procedures. These devices claim to im-
prove patient satisfaction and adherence to treatment
regimens by “calming your nerves” about shots, making
the experience “ouch-less”. In real life, experiences are
variable. SofStic is a disposable single-use device based
on the dental product Accupal [9]. It uses vibrations in
the immediate vicinity of the intended injection to re-
duce pain by supposedly creating a small area of numb-
ness that includes the injection site. The reusable wand
is listed at $125 US dollars and a package of 100 dispos-
able single use tips costs $200 US dollars. The Vibration
Anesthesia Device by Blain Labs is another product that
uses vibration to produce a local anesthetic effect, re-
portedly reducing pain associated with injections [10].
There are no PubMed listed studies of any device aimed
to relieve pain from immunotherapy injections. Assessing
whether these devices improve utilization and/or adherenceto immunotherapy is an exciting direction for future
research.
Social media and other forms of electronic
communications
Use of social media such as email, Facebook, Twitter,
short message service (SMS) also known as text messa-
ging, and YouTube continues to grow. Social media is a
significant part of daily life for both adolescents and
adults and allows for virtual relationships with peers
sharing similar interests. Many allergists have welcomed
social media into their practices. Social media has been
adopted by allergy clinics in a variety of ways such as the
use of Twitter to broadcast daily pollen counts and “al-
lergy shot” hours, Facebook to post photos of the recep-
tion area and staff members, and YouTube videos to
welcome and educate patients and the general public.
Electronic media offer a novel way to potentially im-
prove allergy care. A survey sent to asthma patients be-
tween the ages of 12-40 revealed that e-mail was the
most preferred method to receive asthma information
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only 22% of participants expressed interest in either
receiving information or communicating with a phy-
sician through Facebook [11]. Many of these individuals
were concerned about using Facebook and other social
media because of privacy and noted that their use of
these sites were for social reasons rather than health
information.
A 2012 survey of over 3000 American adults revealed
that 85% own a cell phone, 80% of cell phone owners
send or receive text messages, and 9% of cell phone
users receive text updates or alerts about health or med-
ical issues [12]. Medical professionals are increasingly
finding a role for digital technologies such as text messa-
ging in patient care.
The utility of text messaging was investigated in a ran-
domized controlled trial of 50 patients with allergic rhin-
itis who were assigned to receive either a daily SMS
reminder on their cell phone to take intranasal cortico-
steroid treatment or receive nothing [13]. This study
found that self-reported adherence to medication in the
SMS group was significantly higher than in the control
group. This study suggests that daily SMS reminder im-
proves adherence to medication and treatment outcomes
in allergic rhinitis, however no data exist regarding SMS
messaging in immunotherapy utilization and adherence.
Additionally, this trial was only 30 days long. The effect
of daily SMS on medication adherence is often lost
after additional months, which would be detrimental
for treatments that require long-term compliance such
as immunotherapy.
Current studies of technology use in adolescents with
asthma and allergy do not provide consistent evidence
of effectiveness. The positive attitude toward use of so-
cial media or mobile technology opens the possibility for
future studies to further explore the potential benefits of
such interventions [14].
In today’s world, medical information is widely avail-
able through both print and online media. However, the
sources of information that patients rely on are often
written by non-medical professionals or are based upon
data that lacks credibility or evidence. Both print and
online media may overemphasize, underemphasize, or
misportray certain aspects of disease, leading to patient
misconceptions. Examination of twenty years of news-
paper articles from the New York Times, Los Angeles
Times, and Washington Post revealed that there was rela-
tively little coherence in whether asthma was portrayed as
directly caused by air pollution or triggered by exposures
[15]. Furthermore, outdoor sources of air pollution were
covered more frequently. Studies of print media coverage
of immunotherapy have not been reported. Allergists must
have active online presence to balance the print/online
media coverage that may be incomplete or misguided.While the rise of social media has given physicians
multiple avenues to disseminate information, social
media can also have negative consequences related to
lapses of professionalism and the blurring of the lines
between professional and personal life online [16]. Cau-
tion must be exercised when posting in public forums so
as to not display private patient information or unpro-
fessional behavior. State medical boards and society or-
ganizations have developed specific guidelines on social
media use by physicians.
A recent study used semi-structured interviews to in-
vestigate the perspectives and experiences of physicians
adopting social media in healthcare [17]. Lack of trust
was a major challenge addressed by study participants.
Since anyone can post to social media regardless of edu-
cational and professional qualifications, there is no way
to validate an author’s credentials. Another barrier iden-
tified was information anarchy. This refers to a state
where finding relevant information is challenging due to
the disorganized and chaotic nature of information cre-
ated and disseminated. It can be difficult to navigate
through websites where both social and professional
conversations are taking place between anyone from a
patient to a medical expert upon a backdrop of adver-
tisements, pop-up offers, and marketing banners. Other
challenges identified included difficulty finding time to
use social media, a lack of workplace acceptance and
support, lack of active participation, and concerns sur-
rounding maintaining confidentiality.
Used appropriately, social media offers a powerful
channel for physician and patient education with almost
unlimited distribution. Many scientific societies are ac-
tive users of social media services for dissemination of
quality scientific evidence and patient education mate-
rials. As a practical example, the professional websites of
one of the authors have had more than 10 million page
views and 5 million visitors since 2005, with 5,000 page
views every day. With every hit of the “publish” button
of the sites, the message reaches approximately 30,000
people daily including 30,000 RSS and email subscribers,
15,000 Twitter followers, 2,500 daily visitors, and 3,500
Facebook fans.
Tablet computers for patient education
Technological advancements such as the development of
tablet computers offer a novel way to disseminate infor-
mation and educate patients. The graphic display and
ease of interface makes a tablet computer such as the
iPad™ or Android-based tablet a powerful tool. A 2011
study evaluated the utility of a point-of-care tablet com-
puter (iPad™) for allergy/immunology education. iPads™
preloaded with educational diagrams and clinical photo-
graphs were used to educate patients about allergic rhin-
itis and conjunctivitis and different treatment options,
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veyed, 100% liked the iPad™ to help explain their or their
children’s condition and 100% would like the iPad™ to be
used again to help explain medical information. Patients’
comments included “Showing the pictures helps”, “It
gave me the visual representations”, “It was profes-
sional”, “Having the decision trees to take home was
helpful”, “I like it because you don’t have to use a lot of
paper”, and “If [the pictures/information was] shown on
a computer it wouldn’t have been as convenient and it’s
much better than a verbal description“. While this data
suggest that tablet computers improve patient educa-
tion, future research should assess whether the use of a
tablet computers improves utilization and adherence to
immunotherapy.
Twitter use by allergists for immunotherapy education
and adherence to therapy
Twitter is a fast growing social network that allows for
microblogging and disseminating short pieces of infor-
mation - 140 characters for an individual post, called a
tweet. Twitter has been used by medical professionals to
engage with patients, stay up to date with medical litera-
ture and interact with colleagues [19]. Some allergists
share allergy/immunology news and this can be used as
a form of personalized continuing medical education
(CME) which takes 10 minutes or less several times per
week. Allergy practices also use Twitter to share daily
pollen counts, work hours for immunotherapy (“allergy
shots”) clinic, and physician on call information.
An analysis of allergist and immunologist use of Twitter
conducted for one year (from May 2011 to May 2012)
showed that 85 self-identified allergists were on Twitter in
2012 compared to 18 identified in the prior 2011 study
[20]. This represents a 470% increase (more than 4-fold)
in Twitter use by allergists in one year. Most allergists
were located in the USA (91%), used their professional/
personal name (95%) and had a profile picture (84%).
There were 66 allergy-related organizations identified on
Twitter. Eighty percent of the allergists had more than
50 followers, 64% followed more than 50 users, 79% had
more than 20 tweets, and 78% of the allergists followed at
least one allergist.
Allergists also use Twitter during the annual meetings
of AAAAI, ACAAI, European Academy of Allergy and
Clinical Immunology (EAACI), and World Allergy
Organization (WAO). Physicians, patients, and the gen-
eral public follow the meeting using the name of the
meeting preceded by a hashtag, for example, #AAAAI.
The 2012 AAAAI meeting had 5,041 registered delegates
and 25 allergists (0.49% of the attendees) used Twitter to
publish 2,650 tweets [21]. Their tweets reached 250,000
people, nearly 50 times the number of people who
attended the meeting. Of the tweets, 1,397 (52.7%) werefacts and 7.2% (192) were facts with links to support the
factual information. There were 366 (13.8%) replies, 274
(10.3%) status updates, 219 (8.2%) retweets, 112 (4.2%)
opinions, 46 (1.7%) queries and 25 (0.9%) advertise-
ments. Social media, and Twitter in particular, is an effi-
cient way to disseminate medical information to medical
professionals and the public. A small subset of 25 aller-
gists expanded the educational reach of the 2012 AAAAI
annual meeting to 250,000 individuals.
While twitter activity by allergists has rapidly in-
creased, no literature exists on the efficacy of physician
tweets in improving patient education and medication
compliance. This presents an opportunity for future
studies to further explore the utility of Twitter in making
a meaningful impact on such factors.
YouTube use by allergists for immunotherapy education
YouTube is another platform that has been used to
spread patient education on a wide variety of topics in
medicine. However, as with all forms of social media, the
credibility and quality of information available on
YouTube varies considerably. An analysis of chronic
obstructive pulmonary disease (COPD) patient education
videos on YouTube found that while YouTube has the
potential to reach an inform patients, existing video con-
tent and quality varies significantly. The high-quality videos
were uploaded predominantly by reputable health organi-
zations and qualified medical professionals, not by individ-
ual users [22]. There is a need for more reliable and
accurate patient education videos by physicians and other
qualified medical professionals. At present, organizations
such as AAAAI, ACAAI, and EAACI have YouTube videos
on immunotherapy. Allergists can use YouTube to post
educational videos and then embed them in their website
or blog. For improved efficiency, allergists can also embed
YouTube videos created by reputable health organizations
such as AAAAI, ACAAI, EAACI and WAO.
Online networks for allergists and patients and their role
for immunotherapy research
Online networks provide a forum for allergists and pa-
tients to connect with one another. There are prominent
web-based networks in Italy that link allergy centers and
help share their clinical protocols and epidemiologic
data [23]. For example, the Hospital Allergy Net of
Piemonte, Italy, was established in 2003 and connects
multiple hospitals of the region through a web platform.
A national network called the Italian Pediatric Allergy
Network connects several Italian pediatric allergy units
and adopts a web platform for observational and inter-
vention studies on pediatric asthma and allergies.
In the US, an Allergy/Immunology (A/I) Interest Group
was created at University of Chicago on Google+. The
Google document with scholarly activity has been shared
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the document a total of 38 times and listed 28 unique
projects. Since August 2011, members have generated
and published 5 peer reviewed articles, 10 national
abstract presentations, and 2 book chapters. Five mem-
bers have successfully matched in allergy/immunology
fellowship, 2 are currently applying, and 2 have future
plans to apply.
Electronic surveys assess immunotherapy practices and
utilization
Electronic online surveys have been used to assess
utilization of immunotherapy and practice patterns of
allergen immunotherapy administration. SLIT is a widely
used form of specific immunotherapy in Europe. Due to
the lack of Food and Drug Administration (FDA)-
approved SLIT products in the U.S., it has not been as
widely adopted in the US. However, an electronic
survey sent to practicing allergists in the US in 2011
surprisingly showed that the rates of SLIT use have
nearly doubled in the last 4 years, with 11.4% of US
respondents (59 out of 519 respondents) reporting
SLIT use [24]. It is anticipated that once the FDA-
approved product is available, there will be widespread
use of SLIT in the US.
Allergen immunotherapy practice patterns have also
been identified via electronic survey. A 2010 electronic
survey was sent to allergists who are members of the
AAAAI to examine the ways allergists administer
immunotherapy [25]. The survey found that most of the
1201 responders practice in an urban or suburban prac-
tice in the US and have been in practice for greater than
10 years. Those in practice for greater than 10 years
were more likely to adjust the dose and frequency of
immunotherapy in pollen season.
In a recent study, online surveys were used to assess
the impact of severe allergies on the lives of young
patients [26]. Patient participants were recruited from a
membership database, allergy clinics, and social media.
Another online survey administered to members, web-
site visitors, and social media followers of the Kids with
Food Allergy Foundation showed that differences in
beliefs and opinions about oral immunotherapy (OIT)
existed between OIT participants and nonparticipants
[27]. This demonstrated that thorough and accurate in-
formation about OIT safety, efficacy, risks, and approval
status was not universally conveyed. Use of electronic
surveys in the future may help clinicians identify barriers
to immunotherapy administration and delivery such as
inconsistent patient education.
Conclusion
We are in an era where technology and social media are
omnipresent and influence the daily lives of patients andphysicians. Allergists are using these mediums to at-
tempt to improve patient care and compliance to treat-
ment regimens. While we are seeing an increase in use
of technology and electronic communication channels
by allergists, there is a paucity of information in the lit-
erature on how these interventions affect patient
outcomes. Future studies should be directed towards
investigating how technology and social media improve
the utilization and adherence of immunotherapy.
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